| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a933a0dd561e3e50b278738704d5c6e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18d92c46f60af8af24e262b67381d7eb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2007-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de66b5648f6d18b0b1659bf5fc94e8bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f24b672458449b52e756f6bf0100399
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a04ae577cc35227cfd5256c4bd7c35b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e05b2b454aa13acb00c95e24a95cdf1f |
| publicationDate |
2015-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2543015-T3 |
| titleOfInvention |
Cancer chemoprevention strategy based on the loss of the IGF2 imprint |
| abstract |
A method of determining a pharmacological intervention strategy for an individual, the method comprising determining an imprint loss status (LOI) of insulin-like growth factor type 2 (IGF2), from a sample taken from the individual; and determining a pharmacological intervention strategy for the individual based on the determined LOI status, in which the individual has an LOI and therefore is or is at risk of developing colorectal cancer, the intervention strategy comprises administering to the individual an inhibitor of signal pathway activation by IGF2 and, if the individual does not have an LOI, the intervention strategy does not comprise administering said inhibitor to the individual. |
| priorityDate |
2006-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |